SCOLR PHARMA, INC.

Profile

Company Names

SCOLR PHARMA, INC.

Addresses

13400 NE 20TH STREET, SUITE 44, BELLEVUE, WA 98005

19204 NORTH CREEK PARKWAY, SUITE 100, BOTHELL, WA 98011

Phone Numbers

425-368-1050
4253681050

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$5,633,200.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2012-05-04 
$308,000.00 
$1,350,000.00 
$1,042,000.00 
Debt 
2
2011-06-16 
$1,195,200.00 
$1,195,200.00 
$0.00 
Debt 
1
2010-03-04 
$4,130,000.00 
$4,130,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARYLOU 
W 
ARNETT 
DIRECTOR
SCOLR PHARMA, INC.
MARYLOU 
W. 
ARNETT 
DIRECTOR
SCOLR PHARMA, INC.
RANDALL 
L-W 
CAUDILL 
DIRECTOR
SCOLR PHARMA, INC.
CARL 
J 
JOHNSON 
DIRECTOR
SCOLR PHARMA, INC.
CARL 
J. 
JOHNSON 
DIRECTOR
II-VI INC   |  SCOLR PHARMA, INC.
RICHARD 
M 
LEVY 
EXECUTIVE OFFICER
SCOLR PHARMA, INC.
HERBERT 
L 
LUCAS 
DIRECTOR
SCOLR PHARMA, INC.
HERBERT 
L. 
LUCAS 
DIRECTOR
SCOLR PHARMA, INC.
BRUCE 
S 
MORRA 
DIRECTOR
SCOLR PHARMA, INC.
WAYNE 
L 
PINES 
DIRECTOR
SCOLR PHARMA, INC.
WAYNE 
L. 
PINES 
DIRECTOR
SCOLR PHARMA, INC.
JEFFREY 
B 
REICH 
DIRECTOR
SCOLR PHARMA, INC.
JEFFREY 
B. 
REICH 
DIRECTOR
SCOLR PHARMA, INC.
MICHAEL 
N 
TAGLICH 
DIRECTOR, PROMOTER
DILON TECHNOLOGIES INC   |  SCOLR PHARMA, INC.   |  AIR INDUSTRIES GROUP
MICHAEL 
N. 
TAGLICH 
DIRECTOR
SIMKAR INVESTORS, LLC   |  ABC PEANUT BUTTER, LLC   |  AIR INDUSTRIES GROUP, INC.   |  SCOLR PHARMA, INC.   |  DILON TECHNOLOGIES INC   |  BRIDGELINE DIGITAL, INC.   |  MARE ISLAND DRY DOCK INVESTMENT LLC   |  AIR INDUSTRIES GROUP   |  DECISIONPOINT SYSTEMS, INC.
STEPHEN 
J 
TURNER 
EXECUTIVE OFFICER
SCOLR PHARMA, INC.
STEPHEN 
J. 
TURNER 
EXECUTIVE OFFICER
SCOLR PHARMA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2012-05-18
D
Link
PHARMACEUTICALS 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Debt 
2012-05-04 
2011-06-30
D/A
Link
PHARMACEUTICALS 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Debt 
2011-06-16 
2011-06-23
D
Link
PHARMACEUTICALS 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Debt 
2011-06-16 
2010-03-18
D
Link
PHARMACEUTICALS 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2010-03-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
TAGLICH BROTHERS, INC.
29102
TAGLICH BROTHERS, INC.
29102
TAGLICH BROTHERS, INC.
29102
TAGLICH BROTHERS, INC.
29102
TAGLICH BROTHERS, INC.
29102
TAGLICH BROTHERS, INC.
29102